Neurostimulation to Treat Refractory Angina Pectoris Pain
Stopped early · Phase 3
Conditions studied: Angina Pectoris
In brief
The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cord through an implanted lead (a flexible insulated wire) that is powered by an implanted battery.
Key facts
- Study ID
- NCT00200070
- Run by
- MedtronicNeuro
- People needed
- 228
- Starts
- 2002-12-01
- Expected to finish
- 2007-04-01
- Last updated by the study team
- 2010-08-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- stable angina pectoris associated with reversible myocardial ischemia and significant coronary artery disease (CAD)
- classified as Canadian Cardiovascular Society (CCS) angina class III or IV
- refractory angina despite receiving optimal/maximal medical treatment
- not a candidate for bypass surgery, angioplasty or stent
You may not qualify if…
- not able to perform exercise treadmill testing
- previously received therapeutic transcutaneous electrical nerve stimulation (TENS) (within 2 years) or any spinal cord stimulation (SCS)
- has an implanted pacemaker/defibrillator (ICD)
Where it is running
- Contact Medtronic for Exact Location — Gainesville, Florida, United States
- Contact Medtronic for Exact Location — Indianapolis, Indiana, United States
- Contact Medtronic for Exact Location — Boston, Massachusetts, United States
- Contact Medtronic for Exact Location — Minneapolis, Minnesota, United States
- Contact Medtronic for Exact Location — Rochester, Minnesota, United States
- Contact Medtronic for Exact Location — Charleston, South Carolina, United States
- Contact Medtronic for Exact Location — Winnipeg, Manitoba, Canada
- Contact Medtronic for Exact Location — Ottawa, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.